{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:57:58Z","timestamp":1792699078200,"version":"4.5.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T00:00:00Z","timestamp":1448064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100001463","name":"American Society of Nephrology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Elevated levels of the phosphate-regulating hormone fibroblast growth factor 23 (FGF23) have been linked to greater risk of fractures in some studies, especially among individuals with chronic kidney disease (CKD). We evaluated FGF23 as a risk factor for bone loss and fractures in the Health, Aging, and Body Composition (Health ABC) study, which is a prospective biracial cohort of well-functioning adults aged 70 to 79 years recruited at two clinical centers in the United States. The sample for the bone mineral density (BMD) analyses consisted of 2234 participants who had at least two serial total hip areal BMD measures. The fracture analyses included 2786 participants, 567 of whom sustained a fracture during a median follow up of 4.95 years. Linear mixed-effects models were used for longitudinal measurements of total hip areal BMD and the proportional subdistribution hazard regression model subject to competing risks of death was used for risk of fracture. The median FGF23 was 46.7 (interquartile range [IQR] 36.7 to 60.2) pg\/mL. The mean annualized percent change in total hip areal BMD did not vary significantly according to FGF23 quartile in all participants (p for trend\u2009=\u20090.70), but the effect was modified by CKD status (adjusted p for interaction &amp;lt;0.001). Among participants with CKD, the unadjusted mean annualized percent change in total hip areal BMD was greater with higher levels of FGF23 (unadjusted p for trend\u2009=\u20090.02), but the trend was attenuated with adjustment for estimated glomerular filtration rate and parathyroid hormone (adjusted p for trend\u2009=\u20090.30). FGF23 was not significantly associated with fracture risk in crude (hazard ratio [HR] per doubling of FGF23, 0.97; 95% CI, 0.85 to 1.12) or adjusted models (HR per doubling of FGF23, 1.02; 95% CI, 0.86 to 1.22), and these findings were not modified by gender or CKD status. FGF23 levels are not associated with bone loss or fracture risk in older adults with low prevalence of CKD. \u00a9 2015 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.2750","type":"journal-article","created":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T23:17:06Z","timestamp":1448147826000},"page":"742-748","source":"Crossref","is-referenced-by-count":53,"title":["Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older Individuals"],"prefix":"10.1093","volume":"31","author":[{"given":"Tamara","family":"Isakova","sequence":"first","affiliation":[{"name":"Center for Translational Metabolism and HealthInstitute for Public Health and Medicine, Northwestern University Feinberg School of MedicineChicagoILUSA"},{"name":"Division of Nephrology and Hypertension, Department of MedicineNorthwestern University Feinberg School of MedicineChicagoILUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Cai","sequence":"additional","affiliation":[{"name":"Center for Translational Metabolism and HealthInstitute for Public Health and Medicine, Northwestern University Feinberg School of MedicineChicagoILUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungwha","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Preventative MedicineNorthwestern University Feinberg School of MedicineChicagoILUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Katz","sequence":"additional","affiliation":[{"name":"Kidney Research InstituteUniversity of WashingtonSeattleWAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A","family":"Cauley","sequence":"additional","affiliation":[{"name":"Department of EpidemiologyGraduate School of Public Health, University of PittsburghPittsburghPAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda F","family":"Fried","sequence":"additional","affiliation":[{"name":"Renal Section, VA Pittsburgh Healthcare SystemUniversity of Pittsburgh School of MedicinePittsburghPAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N","family":"Hoofnagle","sequence":"additional","affiliation":[{"name":"Department of Laboratory MedicineUniversity of WashingtonSeattleWAUSA"},{"name":"Kidney Research InstituteUniversity of WashingtonSeattleWAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Satterfield","sequence":"additional","affiliation":[{"name":"Department of Preventive MedicineUniversity of TennesseeMemphisTNUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara B","family":"Harris","sequence":"additional","affiliation":[{"name":"Laboratory of Epidemiology and Population SciencesNational Institute on Aging, National Institutes of HealthRockvilleMDUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Shlipak","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics, and MedicineUniversity of California San Francisco, and Department of General Internal Medicine, San Francisco VA Medical CenterSan FranciscoCAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J","family":"Sarnak","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of MedicineTufts Medical CenterBostonMAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H","family":"Ix","sequence":"additional","affiliation":[{"name":"Nephrology SectionVeterans Affairs San Diego Healthcare System and Division of Nephrology and Preventive Medicine, University of California, San DiegoSan DiegoCAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Health ABC Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,21]]},"reference":[{"key":"2024021014175413200_jbmr2750-bib-0001","doi-asserted-by":"crossref","first-page":"M101","DOI":"10.1093\/geronj\/45.3.M101","article-title":"Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study","volume":"45","author":"Magaziner","year":"1990","journal-title":"J Gerontol"},{"key":"2024021014175413200_jbmr2750-bib-0002","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2105\/AJPH.84.8.1287","article-title":"Treatment and survival among elderly Americans with hip fractures: a population-based study","volume":"84","author":"Lu-Yao","year":"1994","journal-title":"Am J Public Health"},{"key":"2024021014175413200_jbmr2750-bib-0003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1359\/jbmr.1997.12.1.24","article-title":"Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation","volume":"12","author":"Ray","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024021014175413200_jbmr2750-bib-0004","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jamda.2007.10.001","article-title":"A national perspective of Medicare expenditures for elderly veterans with hip fractures","volume":"9","author":"Bass","year":"2008","journal-title":"J Am Med Dir Assoc"},{"key":"2024021014175413200_jbmr2750-bib-0005","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"key":"2024021014175413200_jbmr2750-bib-0006","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.2009121293","article-title":"Forging forward with 10 burning questions on FGF23 in kidney disease","volume":"21","author":"Wolf","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2024021014175413200_jbmr2750-bib-0007","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"2024021014175413200_jbmr2750-bib-0008","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014175413200_jbmr2750-bib-0009","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"2024021014175413200_jbmr2750-bib-0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2024021014175413200_jbmr2750-bib-0011","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4158\/EP.11.2.108","article-title":"Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes","volume":"11","author":"Zimering","year":"2005","journal-title":"Endocr Pract"},{"key":"2024021014175413200_jbmr2750-bib-0012","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMcpc1104567","article-title":"Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia","volume":"365","author":"Bergwitz","year":"2011","journal-title":"N Engl J Med"},{"key":"2024021014175413200_jbmr2750-bib-0013","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1210\/jc.2013-1152","article-title":"Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study","volume":"98","author":"Jovanovich","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014175413200_jbmr2750-bib-0014","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jbmr.263","article-title":"Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men","volume":"26","author":"Mirza","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2024021014175413200_jbmr2750-bib-0015","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/jbmr.1985","article-title":"Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: the Osteoporotic Fractures in Men (MrOS) study","volume":"28","author":"Lane","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2024021014175413200_jbmr2750-bib-0016","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00198-009-1142-4","article-title":"Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease","volume":"21","author":"Manghat","year":"2010","journal-title":"Osteoporos Int"},{"key":"2024021014175413200_jbmr2750-bib-0017","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00198-011-1838-0","article-title":"FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages","volume":"23","author":"Desjardins","year":"2012","journal-title":"Osteoporos Int"},{"key":"2024021014175413200_jbmr2750-bib-0018","year":"2015"},{"key":"2024021014175413200_jbmr2750-bib-0019","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2024021014175413200_jbmr2750-bib-0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"2024021014175413200_jbmr2750-bib-0021","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2024021014175413200_jbmr2750-bib-0022","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014175413200_jbmr2750-bib-0023","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"White","year":"2000","journal-title":"Nat Genet"},{"key":"2024021014175413200_jbmr2750-bib-0024","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"2024021014175413200_jbmr2750-bib-0025","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"2024021014175413200_jbmr2750-bib-0026","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014175413200_jbmr2750-bib-0027","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"2024021014175413200_jbmr2750-bib-0028","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2024021014175413200_jbmr2750-bib-0029","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2024021014175413200_jbmr2750-bib-0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","article-title":"Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study)","volume":"60","author":"Ix","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2024021014175413200_jbmr2750-bib-0031","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int"},{"key":"2024021014175413200_jbmr2750-bib-0032","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"key":"2024021014175413200_jbmr2750-bib-0033","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"2024021014175413200_jbmr2750-bib-0034","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD","volume":"25","author":"Scialla","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2024021014175413200_jbmr2750-bib-0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"key":"2024021014175413200_jbmr2750-bib-0036","doi-asserted-by":"crossref","first-page":"E1636","DOI":"10.1152\/ajpendo.00396.2007","article-title":"Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice","volume":"293","author":"Liu","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024021014175413200_jbmr2750-bib-0037","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res"},{"key":"2024021014175413200_jbmr2750-bib-0038","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","article-title":"Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro","volume":"23","author":"Wang","year":"2008","journal-title":"J Bone Miner Res"},{"key":"2024021014175413200_jbmr2750-bib-0039","doi-asserted-by":"crossref","first-page":"e1000154","DOI":"10.1371\/journal.pgen.1000154","article-title":"Genetic evidence of serum phosphate-independent functions of FGF-23 on bone","volume":"4","author":"Sitara","year":"2008","journal-title":"PLoS Genet"},{"key":"2024021014175413200_jbmr2750-bib-0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00223-011-9501-5","article-title":"Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization","volume":"89","author":"Shalhoub","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"2024021014175413200_jbmr2750-bib-0041","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00223-015-0013-6","article-title":"Biphasic effects of vitamin D and FGF23 on human osteoclast biology","volume":"97","author":"Allard","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"2024021014175413200_jbmr2750-bib-0042","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/8756-3282(87)90015-9","article-title":"Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study","volume":"8","author":"Burkhardt","year":"1987","journal-title":"Bone"},{"key":"2024021014175413200_jbmr2750-bib-0043","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1016\/8756-3282(95)00180-L","article-title":"Role of cytokines in bone resorption","volume":"17","author":"Manolagas","year":"1995","journal-title":"Bone"},{"issue":"2","key":"2024021014175413200_jbmr2750-bib-0044","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.ajkd.2014.07.007","article-title":"Serum bicarbonate and bone mineral density in US adults","volume":"65","author":"Chen","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2024021014175413200_jbmr2750-bib-0045","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","author":"Nickolas","year":"2013","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2750","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/31\/4\/742\/56649632\/jbmr2750.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/31\/4\/742\/56649632\/jbmr2750.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:55:32Z","timestamp":1710341732000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/31\/4\/742-748\/7605211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,21]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,11,21]]},"published-print":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2750","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,4,1]]},"published":{"date-parts":[[2015,11,21]]}}}